
资料发布时间:2018-10-30 14:50:00 最后更新时间: 2021-06-09 15:17:08
【药品简介】 Trametinib是丝裂原活化的细胞外信号调节激酶1(MEK1)和MEK2激酶活性的可逆性抑制剂。MEK蛋白质是细胞外信号相关激酶(ERK)通路的上游调节器,促进细胞增殖。曲美替尼通过抑制MEK可以抑制BRAF V600突变-阳性的癌细胞生长。
【适应症状】 Trametinib,1)单药或与达拉菲尼联和用于BRAF V600E或V600K突变的不可切除或转移性黑色素瘤。 2) 联合达拉菲尼用于BRAF V600E突变-阳性转移性非小细胞性肺癌(NSCLC)。
【 药品别名 】 曲美替尼 Trametinib
印度Trametinib(曲美替尼 Trametinib)价格,正品图片,治疗肺癌药物, 购买Trametinib请到印度药房官方网站进行购买 【印度药房大全目录】
【 市场参考价格 】 ¥10500.00~13500.00
播放/暂停

生物活性
|
产品描述 |
Trametinib is an ATP-noncompetitive inhibitor of MEK 1/2 (IC50s: 0.7/0.9 nM). It shows low inhibition for more than 180 kinases, including B-Raf, c-Raf, and MEK5. |
|
靶点活性 |
MEK1,0.92nM MEK2,1.8nM |
|
实验溶液 |
30% PEG400+0.5% Tween80+5% propylene glycol: 15 mg/mL |
|
体外活性 |
Trametinib (JTP-74057) inhibited the phosphorylation of MBP regardless of the isotype of Raf and MEK (IC50s: 0.92 to 3.4 nM). JTP-74057 demonstrated no inhibition of the kinase activities of c-Raf, B-Raf, ERK1 and ERK2. HT-29 and COLO205 cells, which are known to have a constitutively active B-Raf mutant, were most sensitive to JTP-74057, showing subnanomolar IC50 values. The cell lines bearing a K-Ras mutation showed a wide range of sensitivity to JTP-74057 [1]. Among KRAS mutant cell lines, cell lines with an expression pattern suggestive of epithelial-to-mesenchymal transition were less sensitive to GSK1120212. A proportion of cell lines from certain tissue types not known to carry frequent RAF/RAS mutations also seemed to be sensitive to GSK1120212 [2]. |
|
体内活性 |
Both 0.3 mg/kg and 1 mg/kg of JTP-74057 were effective in inhibiting the HT-29 xenograft growth, and 1 mg/kg of JTP-74057 blocked the tumor increase almost completely. Neither significant changes in body weight nor gross lesions at autopsy were observed in the mice treated with 1 mg/kg of JTP-74057. The phosphorylation of ERK1/2 was completely inhibited in the established tumor tissues by a single oral dose of 1 mg/kg JTP-74057, and both p15INK4b and p27KIP1 protein levels were upregulated after 14 days of treatment with JTP-74057 [1]. JTP-74057 blocked tumor necrosis factor-α and interleukin-6 production from PBMCs. AIA and CIA development were suppressed almost completely by 0.1 mg/kg of JTP-74057. In the CIA, JTP-74057 suppressed collagen-reactive T-cell proliferation ex vivo [3]. |
|
激酶实验 |
Raf-MEK-ERK cascade kinase assay: Non-phosphorylated myelin basic protein (MBP) is coated onto an ELISA plate, and the active form of B-Raf/c-Raf is mixed with unphosphorylated MEK1/MEK2 and ERERK2 in 10 μM ATP and 12.5 mM MgCl2 containing MOPS buffer in the presence of various concentrations of GSK1120212. The phosphorylation of MBP is detected by the anti-phospho-MBP antibody. |
|
细胞实验 |
Exponentially growing cells are precultured in 96-well tissue culture plates for 24 hours and then exposed to GSK1120212. Cell growth is determined by an in vitro toxicology assay kit, sulforhodamine B based. For apoptosis assay, both floating and adherent cells are collected and fixed with 70% ethanol. After washing with PBS, the cells are suspended in 100 μg/mL RNase and 25 μg/mL propidium iodide (PI) and incubated at 37 °C for 30 minutes in the dark. The DNA content of each single cell is determined using the flow cytometer Cytomics FC500 or Guava EasyCyte plus.(Only for Reference) 细胞系: HT-29, HCT-15, HCT116, COLO205, LS-174T, SW480, SW620, T84, LoVo and COLO320 |
|
动物实验 |
动物模型:FeBALB/c-nu/nu mice inoculated subcutaneously with HT-29 or COLO205 cells |
化学信息
|
分子量 |
615.39 |
|
分子式 |
C26H23FIN5O4 |
|
CAS |
871700-17-3 |
|
溶解度 |
DMSO: 21 mg/mL (34.1 mM) Ethanol: <1 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble ) |
|
储存条件 |
store at -80°C |
|
备注 |
For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. |
配制溶液
| 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.625 ml | 8.125 ml | 16.25 ml |
| 5 mM | 0.325 ml | 1.625 ml | 3.25 ml |
| 10 mM | 0.162 ml | 0.812 ml | 1.625 ml |
| 50 mM | 0.032 ml | 0.162 ml | 0.325 ml |
参考文献

【药品特色】曲美替尼治疗伴有BRAF V600E或V600K突变的不可切除或转移性黑色素瘤。曲美替尼和达拉菲尼此两款药为......

【用法用量】 推荐用量: 1)甲状腺髓样癌:每次140mg,每日一次,轻度及中度肝损伤患者起始剂量为80mg 2)肾癌、......

【用法用量】 1)推荐剂量:2mg/day,口服,每日一次;在相同时间服用,直到疾病进展或出现不可耐受的毒性。 2)至少......

用法用量】 1)推荐剂量:每次450mg,每天一次,同食物一起服用;长期服用直至疾病出现新的进展或出现不可耐受的毒副作用......

【作用机制】 克唑替尼是一个酪氨酸激酶受体抑制剂,抑制间变性淋巴瘤激酶(ALK),肝细胞生长因子(HGFR,c-MET)......

作用机制: 奥希替尼是一个EGFR酪氨酸激酶抑制剂,不可逆的与特定的EGFR突变结合,包括T790M,L858R和19号......

不良反应: 鳞癌患者(有转移):用于含铂方案化疗肿瘤继续进展者。 作用机制: 高选择性ErbB抑制剂,不可逆的结合酪氨酸......

【给药方法】 每天一次,空腹服用(饭前一小时或饭后2小时) 厄洛替尼单药用于非小细胞肺癌的推荐剂量为150mg/日,至少......

【作用机制】 吉非替尼是一个酪氨酸激酶抑制剂(TKI),可逆性的抑制特定类型的EGFR突变。EGFR(表皮生长因子受体)......

克唑替尼是一种新型的间变性淋巴瘤激酶(ALK)/间充质上皮生长因子(c-MET)/肝细胞生长因子受体(HGFR)激酶小分......

吉非替尼作为一种EGFR抑制剂,其作用机制主要是通过抑制EGFR自身磷酸化来阻断传导和抑制肿瘤细胞增殖,从而实现肺癌患者......

黑色素瘤是最常见的致命性皮肤肿瘤。目前,治疗早期黑色素瘤的首选方法是手术切除和辅助免疫治疗。大多数晚期和转移性黑色素瘤主......

盐酸厄洛替尼片是一种安全性高、副作用小的口服肺癌靶向药物。它不仅能显著延长患者的生存期,而且能显著提高患者的生活质量。但......

曲美替尼在黑色素瘤治疗领域是众所周知的,为许多病人延长了他们的生命,因为它具有极好的控制癌细胞的能力,这是病人及其家属最......

预防肺癌的方法为远离五气,大气污染属于政府行为,其他四气可由自己掌控,包括戒烟、绿色装修...
Pharmacy Catalogue
【代购】【有实体店】【在线客服懂中文】
代购+直邮,印度抗癌药跨境医药电商直邮服务,让肿瘤患者能够有更好的选择,平台提供印度就医,印度易瑞沙,吉三代,吉二代,索......
【禁止中国访问 】【印度连锁】【品牌实力】
MedPlus是印度第二大药房连锁店。它经营1555家商店,其中1317家为公司所有,159家为特许经营公司,43家为医......
【药品种类丰富 】【渠道正规】【价格较高】
Wellness Forever是一家生活方式零售药房连锁店,致力于为印度本土客户提供全面的健康服务。目前总收入约为62......
【visa/万事达】 【全球可邮 】【纯线上销售】【可开处方】
Netmeds.com致力于开发印度本土市场,已成为印度领先的在线药店。Netmeds.com通过其全天候在线门户和移动......